API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
90
PharmaCompass offers a list of Carisbamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carisbamate manufacturer or Carisbamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carisbamate manufacturer or Carisbamate supplier.
PharmaCompass also assists you with knowing the Carisbamate API Price utilized in the formulation of products. Carisbamate API Price is not always fixed or binding as the Carisbamate Price is obtained through a variety of data sources. The Carisbamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carisbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carisbamate, including repackagers and relabelers. The FDA regulates Carisbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carisbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Carisbamate supplier is an individual or a company that provides Carisbamate active pharmaceutical ingredient (API) or Carisbamate finished formulations upon request. The Carisbamate suppliers may include Carisbamate API manufacturers, exporters, distributors and traders.
click here to find a list of Carisbamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carisbamate DMF (Drug Master File) is a document detailing the whole manufacturing process of Carisbamate active pharmaceutical ingredient (API) in detail. Different forms of Carisbamate DMFs exist exist since differing nations have different regulations, such as Carisbamate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carisbamate DMF submitted to regulatory agencies in the US is known as a USDMF. Carisbamate USDMF includes data on Carisbamate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carisbamate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carisbamate suppliers with USDMF on PharmaCompass.
Carisbamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carisbamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carisbamate GMP manufacturer or Carisbamate GMP API supplier for your needs.
A Carisbamate CoA (Certificate of Analysis) is a formal document that attests to Carisbamate's compliance with Carisbamate specifications and serves as a tool for batch-level quality control.
Carisbamate CoA mostly includes findings from lab analyses of a specific batch. For each Carisbamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carisbamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Carisbamate EP), Carisbamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carisbamate USP).